Stable knockdown of heparanase expression in gastric cancer cells in vitro

Li-Duan Zheng; Guo-Song Jiang; Jia-Rui Pu; Hong Mei; Ji-Hua Dong; Xiao-Hua Hou; Qiang-Song Tong; Servin, Alain L.
November 2009
World Journal of Gastroenterology;11/21/2009, Vol. 15 Issue 43, p5442
Academic Journal
AIM: To develop short hairpin RNA (shRNA) against heparanase, and to determine its effects on heparanase expression and the malignant characteristics of gastric cancer cells. METHODS: Heparanase-specific shRNA was constructed and transferred into cultured the gastric cancer cell line SGC-7901. Stable subclonal cells were screened by G418 selection. Heparanase expression was measured by reverse transcriptase-polymerase chain reaction (RT-PCR), real-time quantitative PCR and Western blotting. Cell proliferation was detected by 2-(4,5-dimethyltriazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) colorimetry and colony formation assay. The in vitro invasiveness and metastasis of cancer cells were measured by cell adhesion assay, wound healing assay and matrigel invasion assay. The angiogenesis capabilities of cancer cells were measured by tube formation of endothelial cells. RESULTS: Stable transfection of heparanase-specific shRNA, but not of scrambled shRNA and mock vector, resulted in reduced mRNA and protein levels of heparanase. The shRNA-mediated knockdown of heparanase did not affect the cellular proliferation of SGC-7901 cells. However, the in vitro invasiveness and metastasis of cancer cells were decreased after knockdown of heparanase. Moreover, transfection of heparanase-specific shRNA decreased the in vitro angiogenesis capabilities of SGC-7901 cells. CONCLUSION: Stable knockdown of heparanase can efficiently decrease the invasiveness, metastasis and angiogenesis of human gastric cancer cells. In contrast, stable knockdown of heparanase does not affect the cell proliferation.


Related Articles

  • Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression. Weizhao Peng; Shuang Si; Qingxia Zhang; Chaofeng Li; Fang Zhao; Fang Wang; Jia Yu; Ren Ma // Journal of Experimental & Clinical Cancer Research (17569966);Aug2015, Vol. 34 Issue 1, p1 

    Background: Long noncoding RNAs (lncRNAs) have recently emerged as important regulators in governing fundamental biological processes, and many of which are likely to have functional roles in tumorigenesis. Maternally expressed gene 3 (MEG3) gene encodes a lncRNA whose expression is lost in an...

  • A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion. Zhao, Jun-hua; Sun, Jing-xu; Song, Yong-xi; Chen, Xiao-wan; Yang, Yu-chong; Ma, Bin; Wang, Jun; Gao, Peng; Wang, Zhen-ning // Journal of Cancer Research & Clinical Oncology;Mar2016, Vol. 142 Issue 3, p601 

    Purpose: Long noncoding RNA (lncRNA) have been reported to be involved in the development of multiple cancers. The aim of this study was to report the identification of lncRNA-CTD-2108O9.1, which we have named lncRNA low expressed in gastric cancer (lncRNA-LOWEG), and investigate its role in...

  • Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2. Yong-Jun Wang; Jian-Zhen Liu; Pei Lv; Yi Dang; Jiang-Yan Gao; Yong Wang // American Journal of Cancer Research;2016, Vol. 6 Issue 11, p2651 

    Dysregulation of long non-coding RNAs (lncRNAs) play important roles in tumor development and progression. The long non-coding RNA CCAT2 has been identified to be up-regulated in gastric cancer (GC). However, the detailed molecular mechanism of CCAT2 involved in GC progression is still unknown....

  • Paeonol inhibits the growth of gastric cancer cells via suppressing HULC expression. Shimin Yang; Xu Wang; Gang Zhong // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 7, p13900 

    Amis: The long noncoding RNAs (lncRNAs) are closely associated with tumor proliferation, differentiation, apoptosis and metastasis. The traditional Chinese medicine, paeonol, has been reported to have an obvious anticancer effect in many types of tumors. However, it was unknown whether paenonl...

  • MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells. Lee, Yong Joo; Han, Myoung-Eun; Baek, Su-Jin; Kim, Seon-Young; Oh, Sae-Ock // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    MED30 is an essential member of the mediator complex that forms a hub between transcriptional activators and RNA polymerase II. However, the expressions and roles of MED30 have been poorly characterized in cancer. In this study, we examined the functional roles of MED30 during gastric cancer...

  • mi-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17. Jiang-Tao Chen; Kun-Hou Yao; Long Hua; Li-Ping Zhang; Chen-Yu Wang; Jun-Jie Zhang // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 9, p10922 

    Background: MicroRNAs (miRNA) have been documented playing a critical role in cancer progression. Although mi-338-3p has been implicated in several cancers, its role in gastric cancer is still unknown. The aim of our study was to investigate the role of mi-338-3p in gastric cancer progression....

  • Four resections for hepatic metastasis from gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis. Koide, Naohiko; Watanabe, Hiroyuki; Shimozawa, Nobuhiko; Hanazaki, Kazuhiro; Kajikawa, Shoji; Adachi, Wataru; Amano, Jun // Journal of Gastroenterology;2000, Vol. 35 Issue 2, p150 

    Abstract: In a patient with gastric cancer (GC) associatedwith one synchronous and three metachronoushepatic metastases (HM), who underwent four hepatectomies, we carried out histochemical investigations regarding cell proliferation, apoptosis, and angiogenesisin the GC and HM. Tissue samples...

  • Invasion and metastasis in pancreatic cancer. Keleg, Shereen; Büchler, Peter; Ludwig, Roman; Büchler, Markus W.; Friess, Helmut // Molecular Cancer;2003, Vol. 2, p14 

    Pancreatic cancer remains a challenging disease with an overall cumulative 5-year survival rate below 1%. The process of cancer initiation, progression and metastasis is still not understood well. Invasion and tumor metastasis are closely related and both occur within a tumour-host microecology,...

  • The tumor microenvironment and its contribution to tumor evolution toward metastasis. Lorusso, Girieca; Rüegg, Curzio // Histochemistry & Cell Biology;Dec2008, Vol. 130 Issue 6, p1091 

    Cancer cells acquire cell-autonomous capacities to undergo limitless proliferation and survival through the activation of oncogenes and inactivation of tumor suppressor genes. Nevertheless, the formation of a clinically relevant tumor requires support from the surrounding normal stroma, also...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics